-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Pyxis Oncology, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate for Q2 2025.
- Pyxis Oncology, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2025 was $283K.
Income Tax Expense (Benefit), Quarterly (USD)